EYEFILL® C. -US Viscoelastic Clinical Investigation

Inclusion Criteria: * Any race * Older than 21 years * Cataract requiring cataract extraction in at least 1 eye * Clear intraocular media other than cataract * Able to provide written informed consent * Able and willing to comply with required follow-up schedule * Competent to understand the procedure and the actions asked of him/her as a research subject Exclusion Criteria: * Monocular * Ocular infection * History of glaucoma, Ocular Hypertension (IOP \> 21 mmHg) likely to require IOP lowering medications, ocular condition requiring IOP lowering medication, condition preventing reliable Goldmann applanation tonometry, known steroid responder * Previous intraocular surgery in the operative eye * Previous serious corneal disease or known endothelial cell loss / damage (in operative eye) * History of chronic or recurrent inflammatory eye disease (in operative eye) * Evidence of retinal vascular disease (in operative eye) * Uncontrolled diabetes or proliferative diabetic retinopathy * Acute or chronic disease or illness that would increase the operative risk * Allergy to anesthetics or other postoperative medications * Known hypersensitivity to sodium hyaluronate or other components in viscoelastic * Patient in any other clinical trial within the 30 days prior to the start of the study